Arie Regev
- Epidemiology top 0.5%
- Hepatology top 0.2%
- Surgery top 5%
- Pharmacology top 1%
- Transplantation top 1%
- Co-authors
- Eugene R. SchiffLennox J. JeffersEnrique MolinaK. Rajender ReddyMariana BerhoNikolaos PyrsopoulosClara MilikowskiAyse L. Mindikoglu
- Topics
- Liver Disease Diagnosis and Treatment (34 papers)Hepatitis C virus research (29 papers)Drug-Induced Hepatotoxicity and Protection (19 papers)
- Journals
- GastroenterologyHepatologyNeurology
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Arie Regev
93 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Epidemiology 2.8k
- Hepatology 2.6k
- Surgery 936
- Pharmacology 380
- Transplantation 355
Countries citing papers authored by Arie Regev
This map shows the geographic impact of Arie Regev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie Regev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie Regev more than expected).
Fields of papers citing papers by Arie Regev
This network shows the impact of papers produced by Arie Regev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie Regev. The network helps show where Arie Regev may publish in the future.
Co-authorship network of co-authors of Arie Regev
This figure shows the co-authorship network connecting the top 25 collaborators of Arie Regev. A scholar is included among the top collaborators of Arie Regev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arie Regev. Arie Regev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 14 | |
| 4 | 3 | |
| 5 | 24 | |
| 6 | 11 | |
| 7 | 19 | |
| 8 | 2 | |
| 9 | 48 | |
| 10 | 67 | |
| 11 | 142 | |
| 12 | 73 | |
| 13 | 48 | |
| 14 | 33 | |
| 15 | 45 | |
| 16 | 6 | |
| 17 | 15 | |
| 18 | 68 | |
| 19 | 47 | |
| 20 | 9 |
About Arie Regev
Arie Regev is a scholar working on Hepatology, Transplantation and Pharmacology, having authored 95 papers that have together received 4.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (29 papers) and Drug-Induced Hepatotoxicity and Protection (19 papers). The work is most often cited by research in Hepatology (2.6k citations), Transplantation (355 citations) and Epidemiology (2.8k citations). Arie Regev has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Eugene R. Schiff, Lennox J. Jeffers, Enrique Molina, K. Rajender Reddy, Mariana Berho, Nikolaos Pyrsopoulos, Clara Milikowski, Ayse L. Mindikoglu, Andreas G. Tzakis and Meir Lahav. Their work appears in journals such as Gastroenterology, Hepatology and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.